States Step in to Regulate Drug Co-pays
Consurers may need to find new ways to control costs for specialty drugs, as more states add limits to cost-sharing and utilization continues to grow.
Consurers may need to find new ways to control costs for specialty drugs, as more states add limits to cost-sharing and utilization continues to grow.
At least five states have enacted laws limiting copays and two — New York and Alaska — have expressly prohibited the use of tiered formularies for specialty medications. Another 11 states, including California, Illinois and Virginia, have legislation up for consideration that would limit copays.
That state governments are stepping in to place limits on cost-sharing for specialty drugs suggests that public angst over rising out-of-pocket costs is reaching an inflection point—monthly drug costs that were once affordable for patients with conditions like arthritis or multiple sclerosis are becoming harder to cover as part of a family budget. Consumers are seeking relief and lawmakers are turning to insurers to limit what they can charge their members.
Read the full story: http://bit.ly/1vUkCsa
Source: Healthcare Payer News
